Annual Monitoring for Persons on Long-Term Opioid Therapy (AMO)
Identifying Attributes
Care Settings
Primary Care
Country
United States of America
Publishing Organisation
Core Quality Measures Collaborative (CQMC) Consensus Core Set: Accountable Care Organizations (ACOs), Patient Centered Medical Homes (PCMHs), and Primary Care
Type of Quality Indicator
Process
IOM Quality Dimension
Safety
Domain
Medications and Medication Management
Defining Attributes
Definition
The percentage of individuals 18 years of age and older who are on long-term opioid therapy and have not received a drug test at least once during the measurement year.
Numerator
Individuals in the denominator population who have not received a drug test during the measurement year.
Denominator
The target population for this measure is individuals 18 years of age and older and prescribed long-term opioid therapy during the measurement year.
Exclusions
Individuals with: 1) a diagnosis of cancer at any time during the measurement year; or 2) hospice care at any time during the year.
Use of Risk Adjustment
No
Risk Adjustments
None
Stratifications
None
Collection and Reporting Attributes
Type of Data Collection
Administrative data
Data Collection Methods
Reporting is specific to sub-program
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No
Source and Reference Attributes
Evidence Source
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025
Contents
Actions
Date Modified 02 December 2025